-
Alcain FJ, Villalba JM (2007) NQO1-directed antitumour quinones. Expert Opin Ther Pat 17: 649-665.
-
Anusevičius Ž, Nivinskas H, Šarlauskas J, Sari MA, Boucher JL, Čėnas N (2013) Single-electron reduction of quinone and nitroaromatic xenobiotics by recombinant rat neuronal nitric oxide synthase. Acta Biochim Pol 60: 217-222.
-
Begleiter A (2000) Clinical applications of quinone-containing alkylating agents. Frontiers Biosci 5: e153-e171.
-
Cameron DW, Gilles RGF (1968) Photochemical formation of benzoxalizone derivatives from aminated quinones. J Chem Soc C 1461-1464.
-
Čėnas N, Anusevičius Ž, Nivinskas H, Misevičienė L, Šarlauskas J (2004) Structure-activity relationships in two-electron reduction of quinones. Methods Enzymol 382: 258-277.
-
Chou F, Khan AH, Driscoll JS (1976) Potential central nervous system antitumour agents. Aziridinylbenzoquinones. J Med Chem 19: 1302-1308.
-
Danson SJ, Johnson P, Ward TH, Dawson M, Denneny O, Dickinson G, Aarons L, Watson A, Jowle D, Cummings J, Robson L, Halbert G, Dive C, Ranson M (2011) Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1. Ann Oncol 22: 1653-1660.
-
Di Francesco A, Ward TH, Butler J (2004) Diaziridinylbenzoquinones. Methods Enzymol 382: 174-193.
-
Hacker MP, Hong CB, McKee MJ, Unwin SE, Urbanek SA (1982) Toxicity of aziridinylbenzoquinone administrated intra venously to beagle dogs. Cancer Treat Rep 66: 1845-1852.
-
Hargreaves RHJ, Hartley JA, Butler J (2000) Mechanisms of action of quinone-containing alkylating agents: DNA alkylation by aziridinylquinones. Frontiers Biosci 5: e172-e180.